<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang F</submitter><funding>Natural Science Foundation of Chongqing Municipality</funding><funding>Natural Science Foundation Project of Chongqing</funding><funding>Postdoctoral Research Foundation of China</funding><funding>National Natural Science Foundation of China</funding><funding>Chongqing Postdoctoral Science Foundation</funding><pagination>2622-2638</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10404965</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>Protein arginine methyltransferase 1 (PRMT1), a type I PRMT, is overexpressed in gastric cancer (GC) cells. To elucidate the function of PRMT1 in GC, PRMT1 expression in HGC-27 and MKN-45 cells was knocked down by short hairpin RNA (shRNA) or inhibited by PRMT1 inhibitors (AMI-1 or DCLX069), which resulted in inhibition of GC cell proliferation, migration, invasion, and tumorigenesis &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. MLX-interacting protein (MLXIP) and Kinectin 1 (KTN1) were identified as PRMT1-binding proteins. PRMT1 recruited MLXIP to the promoter of β-catenin, which induced β-catenin transcription and activated the β-catenin signaling pathway, promoting GC cell migration and metastasis. Furthermore, KTN1 inhibited the K48-linked ubiquitination of PRMT1 by decreasing the interaction be</pubmed_abstract><journal>Genes &amp; diseases</journal><pubmed_title>PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the β-catenin pathway.</pubmed_title><pmcid>PMC10404965</pmcid><funding_grant_id>cstc2022ycjh-bgzxm0145</funding_grant_id><funding_grant_id>cstc2021jcyj-bsh0067</funding_grant_id><funding_grant_id>82203339</funding_grant_id><funding_grant_id>7820100607</funding_grant_id><funding_grant_id>2021M692679</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Ke X</pubmed_authors><pubmed_authors>Lu M</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Peng S</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Cui H</pubmed_authors><pubmed_authors>Zhong X</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Tang H</pubmed_authors></additional><is_claimable>false</is_claimable><name>PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the β-catenin pathway.</name><description>Protein arginine methyltransferase 1 (PRMT1), a type I PRMT, is overexpressed in gastric cancer (GC) cells. To elucidate the function of PRMT1 in GC, PRMT1 expression in HGC-27 and MKN-45 cells was knocked down by short hairpin RNA (shRNA) or inhibited by PRMT1 inhibitors (AMI-1 or DCLX069), which resulted in inhibition of GC cell proliferation, migration, invasion, and tumorigenesis &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. MLX-interacting protein (MLXIP) and Kinectin 1 (KTN1) were identified as PRMT1-binding proteins. PRMT1 recruited MLXIP to the promoter of β-catenin, which induced β-catenin transcription and activated the β-catenin signaling pathway, promoting GC cell migration and metastasis. Furthermore, KTN1 inhibited the K48-linked ubiquitination of PRMT1 by decreasing the interaction be</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-05T14:51:49.203Z</modification><creation>2025-04-05T14:51:49.203Z</creation></dates><accession>S-EPMC10404965</accession><cross_references><pubmed>37554218</pubmed><doi>10.1016/j.gendis.2023.02.006</doi></cross_references></HashMap>